Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors

29 Jan 2016

Abstract excerpt

IMPORTANCE: Whole-exome sequencing (WES) has the potential to reveal tumor and germline mutations of clinical relevance, but the diagnostic yield for pediatric patients with solid tumors is unknown. OBJECTIVE: To characterize the diagnostic yield of combined tumor and germline WES for children with solid tumors. DESIGN: Unselected children with newly diagnosed and previously untreated central nervous system (CNS)...

Topics

Join the communities discussing this publication.

Cancer Genomics and Diagnostics
Genomics and Rare Diseases
Neuroblastoma Research and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 26822237
DOI: 10.1001/jamaoncol.2015.5699

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid TumorsPMID 26822237Read ↗

Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors—a nationwide, prospective Swedish studySemantic proximity Read ↗

Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical CareSemantic proximity Read ↗

Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With CancerSemantic proximity Read ↗

Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University ExperienceSemantic proximity Read ↗

Pathogenic germline variations and cancer risks in pediatric patients referred for genetic testing.Semantic proximity Read ↗

Molecular Profiling of Hard-to-Treat Childhood and Adolescent CancersSemantic proximity Read ↗

Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptomeSemantic proximity Read ↗

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumorsSemantic proximity Read ↗

Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.Semantic proximity Read ↗

Molecular Diagnostic Outcomes from 700 Cases: What Can We Learn from a Retrospective Analysis of Clinical Exome Sequencing?Semantic proximity Read ↗

Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.Semantic proximity Read ↗

Clinical Impact of Germline Multigene Sequencing in Pediatric Cohorts with a Wide Spectrum of Neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.